ESHRE 2020 Main programme

>> Sunday >> Monday >> Tuesday >> Wednesday




Tuesday 07 July 2020

13:10 - 14:10
COOK MEDICAL : Toward a predictive model for osmolality rise during culture in a non-humidified incubator
Toward a predictive model for osmolality rise during culture in a non-humidified incubator
Chair
13:10 - 13:13
Welcome and introduction
Magdalena Depa-Martynow, Poland
13:13 - 13:20
Culturing an embryo with a focus on humidification
Magdalena Depa-Martynow, Poland
13:20 - 14:00
Toward a Predictive Model for Osmolality Rise During Culture in a Non-Humidified Incubator
Steven Mullen, U.S.A.
14:00 - 14:10
Q & A

10:50 - 11:35
MedITEX : Unlocking the secrets to success: managing clinical pathways digitally
Chair
Unlocking the secrets to success: managing clinical pathways digitally
Berkley Andrew, United Kingdom
10:50 - 11:35
Unlocking the secrets to success: managing clinical pathways digitally
Berkley Andrew, United Kingdom

14:35 - 15:20
FERRING PHARMACEUTICALS : Advancing ART: Conversations of legacies, new data, and a look into the future.
Advancing ART: Conversations of legacies, new data, and a look into the future.
Chair
Bart C.J.M. Fauser, The Netherlands
14:35 - 15:20
Join Bart Fauser in dialogue with:
Nele Brusselaers, Sweden
Kevin Doody, U.S.A.
Livio Casarini, Italy
Juan A. Garcia-Velasco, Spain
Joop Laven, The Netherlands

15:45 - 16:30
GENEA BIOMEDX: IVF Value Chain Optimisation Utilising Technology
15:45 - 16:30
IVF Value Chain Optimisation Utilising Technology │
Teija Peura, Australia

16:50 - 17:50
COOPER SURGICAL: ART imitating Life: the chicken or the egg?
Chair
16:50 - 16:53
Chair
Steven D. Fleming, Australia
16:53 - 17:00
Every step matter
David T. Hansen, Denmark
17:00 - 17:20
Key role of cryopreservation in IVF: When lab technologies help to improve quality and safety of treatments
Laura Francesca Rienzi, Italy
17:20 - 17:43
Quality in the IVF clinic: The patient decides whether it is good enough
Willem Verpoest, Belgium

12:00 - 12:45
KARL STORZ: Life Expert Centre Method - A new approach to uterine diagnosis and treatment?
12:00 - 12:20
Life Expert Centre Method - A new approach to uterine diagnosis and treatment?
Rudi L. Campo, Belgium
12:20 - 12:35
Adenomyosis cause of failed implantation
Stephan Gordts, Belgium
12:35 - 12:45
Q & A

08:30 - 09:30
Session 28: Revisiting early embryo development
Chairs
Thomas Ebner, Austria
Aisling Ahlstrom, Sweden
08:30 - 08:50
Dynamics of the epigenetic landscape in blastocyst development and stem cell models
Peter Rugg-Gunn, United Kingdom
08:50 - 09:10
Cell cycle in the preimplantation embryo: mechanisms, errors, consequences and cell fate
Joris Vermeesch, Belgium
09:10 - 09:30
Discussion

08:30 - 09:30
Session 29: Building bridges towards harmonisation
Chairs
Ioana Adina Rugescu, Romania
Snezana Vidakovic, Serbia
08:30 - 08:50
ESHRE as partner in current and future EU projects
Kersti Lundin, Sweden
08:50 - 09:10
The future of EU legislation on tissues and cells
Deirdre Fehily, Belgium
09:10 - 09:30
Discussion

08:30 - 09:30
Session 30: Nurse or midwife led e-health care interventions
Chairs
Annick Geril, Belgium
Valerie Blanchet De Mouzon, France
08:30 - 08:50
Development and evaluation of a preconception health online learning module for nurses in primary care
Karin Hammarberg, Australia
08:50 - 09:10
The midwife-led development of e-based pre-conception care programme
Ilse Delbaere, Belgium
09:10 - 09:30
Discussion

09:30 - 10:00
Coffee Break Discussion

10:00 - 11:30
Session 31: Predictive algorithms in Clinical Embryology
Chairs
Dean Morbeck, New Zealand
Maria Jose De Los Santos, Spain
10:00 - 10:10
Compared to traditional statistics, using machine learning algorithms increases prediction of euploidy in human embryos from weak (61%) to acceptable (72%)
Stefanie De Gheselle, Belgium
10:10 - 10:20
A universal algorithm is available in last generation time-lapse incubators: embryo score provided by the KIDScoreD5 is strongly correlated with chromosomal status and clinical outcomes.
Lorena Bori, Spain
10:20 - 10:30
Artificial Intelligence (AI) system combining both images and non-image inputs can improve the accuracy of human embryo viability prediction
Isao Miyatsuka, Japan
10:30 - 10:40
Camera-agnostic self-annotating Artificial Intelligence (AI) system for blastocyst evaluation
Matthew VerMilyea, U.S.A.
10:40 - 10:50
Automated evaluation system based on artificial intelligence and visualization technology can effectively improve the accuracy of blastocyst evaluation
Shanshan Wang, China
10:50 - 11:00
The migration speed of nucleolar precursor bodies in pronuclei is a predictor of human embryo development
Taketo Inoue, Japan
11:00 - 11:30
Discussion

10:00 - 11:30
Session 32: Which are the optimal ovarian stimulation protocol?
Chairs
Georg Griesinger, Germany
Julia Bosdou, Greece
10:00 - 10:10
What is the optimal gonadotropin releasing hormone (GnRH) antagonist protocol during ovarian stimulation for assisted reproductive technologies (ART)? A pairwise and network meta-analysis
Christos Venetis, Australia
10:10 - 10:20
Influence of the duration of GnRH-antagonist ovarian-stimulation protocol on IVF outcomes in patients with anovulation, endometriosis, premature ovarian failure (POF) and idiopathic infertility.
Judith Gómez-Martínez, Spain
10:20 - 10:30
Comparison of different progestin regimens for pituitary suppression during ovarian stimulation for assisted reproductive technology, a systematic review
Baris Ata, Turkey
10:30 - 10:40
Superiority of cumulative live birth rates after GnRH antagonist cycles relates to ovarian response: a cycle-specific analysis of data from a Japanese national registry
Seung Chik Jwa, Japan
10:40 - 10:50
Development and validation of a gonadotropin dose-selection model for individualized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis (IPD-MA).
Nienke Schouten, The Netherlands
10:50 - 11:00
Natural micronized progesterone versus a GnRH antagonist in egg-donation cycles. An extended experience.
Juan Carlos Castillo, Spain
11:00 - 11:30
Discussion

10:00 - 11:30
Session 33: Predictors. Technology and processes improving outcomes in andrology
Chairs
Jackson Kirkman-Brown, United Kingdom
Sirpa Makinen, Finland
10:00 - 10:10
Live Births With a Novel ROSI Technique Using Elongating Spermatids for Non Obstructive Azoospermia Patients: A European Cohort Study
Emre Pabuccu, Turkey
10:10 - 10:20
The added value of enzymatic digestion to mechanical mincing in testicular sperm retrieval in non-obstructive azoospermia
Veerle Vloeberghs, Belgium
10:20 - 10:30
Ooplasm-Mediated Sperm Nuclear Decondensation for Heritable Genome Editing of the Mammalian Male Gamete
June Wang, U.S.A.
10:30 - 10:40
A Novel Microfluidics Method for Reliable and Efficient Sperm Sex Selection
Rony Elias, U.S.A.
10:40 - 10:50
Effect of microfluidic sperm separation versus standard sperm washing processes on fertilization rates, blastocyst development and euploidy rates among all infertility patients
Glen Adaniya, U.S.A.
10:50 - 11:00
Testicular cell communication mediated by extracellular vesicles
Ellis Fok, Hong Kong
11:00 - 11:30
Discussion

10:00 - 11:30
Session 34: Endometriosis - pathogenesis and diagnosis
Chairs
Martin Götte, Germany
Carla Tomassetti, Belgium
10:00 - 10:10
Exome-wide screen for somatic mutations in endometriosis lesions
Kenneth Ward, U.S.A.
10:10 - 10:20
The landscape of endometrial transcriptome in ovulatory obese PCOS women
Vesna Salamun, Slovenia
10:20 - 10:30
Three-dimensional ultrasonography versus diagnostic hysteroscopy in the differential diagnosis of intra-uterine benign disease. A single institution experience.
Agnese Maria Lourdes Gambaro, United Kingdom
10:30 - 10:40
Integration of clinical factors and biomarkers for non-invasive diagnosis of endometriosis
Arne Vanhie, Belgium
10:40 - 10:50
Local steroid metabolism in eutopic endometrium and corresponding endometriotic lesions: intra-patient variability
Andrea Romano, The Netherlands
10:50 - 11:00
Exploring the delays to diagnosis of endometriosis in the United Kingdom; a triphasic mixed-methods study
Babu Karavadra, United Kingdom
11:00 - 11:10
Elevated levels of monocyte chemotactic protein-1 (MCP-1) in the follicular fluid reveals different populations among women with severe endometriosis.
Pierre-Emmanuel Bouet, France
11:10 - 11:30
Discussion

10:00 - 11:30
Session 35: Impact of ART on health outcomes of children
Chairs
Kelly Tilleman, Belgium
Anja Pinborg, Denmark
10:00 - 10:10
Differences in the landscape of mitochondrial DNA variants between ART and spontaneously conceived individuals links to maternal infertility and low birth weight
Joke Mertens, Belgium
10:10 - 10:20
Imprinting disorders in children born after assisted reproductive technology (ART): a Nordic study from the CoNARTaS group
Øjvind Lidegaard, Denmark
10:20 - 10:30
ICSI does not increase the odds of adverse perinatal outcomes in autologous/ donor oocyte cycles without male-factor subfertility: analysis of 121,448 singleton live births
Prasanna Raj Supramaniam, United Kingdom
10:30 - 10:40
The risk of major congenital malformations in children conceived after ICSI: a Nordic cohort study
Anna-Karina Henningsen, Denmark
10:40 - 10:50
The DNA methylation patterns within whole blood of adolescents born from IVF are not different from those adolescents conceived naturally within the Raine birth cohort.
Roger Hart, Australia
10:50 - 11:00
Female causes of infertility are associated with higher risk of preterm birth and low birth weight: analysis of 120 902 singleton live births following IVF
Mohan Shashikant Kamath, India
11:00 - 11:10
The risk of cerebral palsy in ART children has more than halved over two decades – a Nordic collaborative study on 55,233 liveborn children
Anne Lærke Spangmose, Denmark
11:10 - 11:30
Discussion

10:00 - 11:45
Session 36: COVID-19 - Lessons learned
Chairs
Anna Veiga, Spain
Edgar Vasile Mocanu, Ireland
10:00 - 10:20
Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy (invited lecture)
Giulia Giordano, Italy
10:20 - 10:30
Is COVID-19 symptomatic triage enough? The limited value of serological testing
Cristina González-Ravina, Spain
10:30 - 10:40
Seroconversion of Immunoglobulins to SARS-CoV-2 of healthcare workers in nine European fertility units
Scott Nelson, United Kingdom
10:40 - 10:50
Streamlining follicular monitoring during controlled ovarian stimulation? A data-driven approach to efficient IVF care in the new era of social distancing
Isla Robertson, United Kingdom
10:50 - 11:00
Maternal-fetal vertical SAR-CoV-2 (COVID-19) viral transmission during pregnancies is possible and currently cannot be dismissed
Gulam Bahadur, United Kingdom
11:00 - 11:10
SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts
Wafaa Essahib, Belgium
11:10 - 11:45
Discussion

11:45 - 12:45
Session 37: MHR symposium - Fundamentals on making oocytes
Chairs
Keith Jones, Australia
Claus Andersen Yding, Denmark
11:45 - 12:05
Major molecular players in creating oocytes from germ cells
Josephine Bowles, Australia
12:05 - 12:25
Influence of genetic and maternal factors on the egg epigenome
Gavin Kelsey, United Kingdom
12:25 - 12:45
Discussion

11:45 - 12:45
Session 38: Laboratory session - Time-lapse in 2020
Chairs
Kersti Lundin, Sweden
Anette Vestergaard Gabrielsen, Denmark
11:45 - 12:05
Time-lapse technology: Lights and shadows of clinical evidence
Aisling Ahlstrom, Sweden
12:05 - 12:25
How TLT is changing our understanding and research on embryo development?
Thomas Freour, France
12:25 - 12:45
Discussion

11:45 - 12:55
Session 39: Strategies to improve the outcomes of ovarian stimulation 2
Chairs
Basil C. Tarlatzis, Greece
Stamatina Iliodromiti, United Kingdom
11:45 - 11:55
Impact of different strategies in frozen cycles in normo responding patients undergoing IVF/ICSI cycles: a multicenter cohort study
Charalampos Siristatidis, Greece
11:55 - 12:05
Follicular flushing leads to higher oocyte yield in monofollicular natural cycle IVF – a randomized controlled trial
Alexandra Kohl Schwartz, Switzerland
12:05 - 12:15
Do we trust in evidence based medicine? A multicentre retrospective analysis of 2677 first IVF/ICSI cycles before and after the OPTIMIST trial.
Enrico Papaleo, Italy
12:15 - 12:25
Experience in random-start ovarian stimulation in cancer patients
Yana Martirosyan, Russia C.I.S.
12:25 - 12:35
Pituitary supression is not necessary for blocking LH surge during luteal-phase stimulation
Maria Cruz Palomino, Spain
12:35 - 12:55
Discussion

13:00 - 14:00
Break

14:00 - 14:45
Session 40: Global ART Monitoring
Chairs
Jacques De Mouzon, France
Markus S. Kupka, Germany
14:00 - 14:30
ICMART preliminary world report 2016
Geoffrey David Adamson, U.S.A.
14:30 - 14:45
SET in a global perspective. Regional similarities and differences
Osamu Ishihara, Japan

14:00 - 15:00
Session 41: ALMER exchange session - IVF laboratory automation
Chairs
Ester Polak de Fried, Argentina
Newton Busso, Brazil
14:00 - 14:20
Cons
Catherine Racowsky, France
14:20 - 14:40
Pros
Gary D. Smith, U.S.A.
14:40 - 15:00
Discussion

14:00 - 15:00
Session 42: Stress and infertility - The chicken or the egg
Chairs
Giuliana Baccino, Spain
Lone Schmidt, Denmark
14:00 - 14:20
Just relax and it will happen?: the case for stress causing lack of pregnancy
Jacky Boivin, United Kingdom
14:20 - 14:40
Just relax and it will happen?: The case against stress as a cause of infertility
Angela Lawson, U.S.A.
14:40 - 15:00
Discussion

15:15 - 16:30
Session 43: ICSI in 2020
Chairs
Borut Kovacic, Slovenia
Lucia De Santis, Italy
15:15 - 15:25
Advancement in the future automation of ICSI: Use of deep convolutional neural networks (CNN) to identify precise location to inject sperm in mature human oocytes
Jessica Dickinson, U.S.A.
15:25 - 15:35
The application of AOA-artificial oocyte activation in patients with previous unsuccessful attempt increases the ongoing pregnancy per treatment but not per transfer; a multivariable study
Aránzazu Galán Rivas, Spain
15:35 - 15:45
Toward an ICSI chip: automated microfluidic oocyte denudation module
Amir Mokhtare, U.S.A.
15:45 - 15:55
Marginal differences in preimplantation development between conventional IVF and ICSI in patients with non-male factor infertility: a sibling oocyte study.
Neelke De Munck, United Arab Emirates
15:55 - 16:05
Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with non-male factor infertility: a randomised controlled trial
Vinh Q Dang, Vietnam
16:05 - 16:30
Discussion

15:15 - 16:30
Session 44: What are the optimal regimes for frozen embryo transfer?
Chairs
Ying Cheong, United Kingdom
Carlo Alviggi, Italy
15:15 - 15:25
Natural cycle frozen-thawed embryo transfer (FET): A comparison of outcomes following blastocyst transfer on day six versus day seven after urinary luteinising hormone (LH) surge.
Matt Noble, United Kingdom
15:25 - 15:35
Pregnancy outcome and cost-effectiveness comparisons of artificial cycle-prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomized controlled trial
Lu Luo, China
15:35 - 15:45
Safety and IVF outcomes of Day 6 vitrified blastocyst transfers : comparison with Day 5 vitrified blastocyst transfers with propensity score matching
Dong Soo Park, Korea, South
15:45 - 15:55
Comparison of day-5 serum progesterone levels using different routes of administration for artificial endometrial preparation: Intrapatient variation.
Maria Cerrillo Martínez, Spain
15:55 - 16:05
Frozen-thawed embryo transfer in natural cycles leads to higher clinical pregnancy rates compared to artificial endometrial preparation cycles
Nardin Aslih, Israel
16:05 - 16:30
Discussion

15:15 - 16:15
Session 45: Spermatogenesis subtle regulatory effectors
Chairs
Sheena E. M. Lewis, United Kingdom
Verena Nordhoff, Germany
15:15 - 15:25
Environmental pollution affects the protamine-histone content in human sperm and changes their properties making able to promote DNA oxidative damage: the contribution of molecular investigations.
MARINA PISCOPO, Italy
15:25 - 15:35
Beta2-adrenergic receptors are mainly expressed in the terminal piece of the human sperm flagellum
Jose Luis Girela, Spain
15:35 - 15:45
A novel approach for male contraception: modulation of phosphoprotein phosphatase 1 complexes using bioportides
Joana Silva, Portugal
15:45 - 15:55
In vitro co-exposure to Benzo(a)pyrene (B(a)P) and aged cerium dioxide nanoparticles (CeO2NPs) enhances DNA damage in human and rat gametes
Jeanne Perrin, France
15:55 - 16:15
Discussion

15:15 - 16:15
Session 46: Reproductive (epi)genetics 2
Chairs
Stéphane Viville, France
Aafke Van Montfoort, The Netherlands
15:15 - 15:25
Non-invasive metabolic imaging with fluorescence lifetime imaging microscopy (FLIM) detects differences in ploidy of human blastocysts
Jaimin Shah, U.S.A.
15:25 - 15:35
Single tube long fragment read (stLFR) with massively parallel sequencing achieved patient-only haplotyping for preimplantation genetic testing of monogenic disorders
Songchang Chen, China
15:35 - 15:45
First report about preimplantation genetic testing for the Xq24 microdeletion related to X-linked mental retardation, Nascimento type in a woman with recurrent pregnancy loss
Igor Lebedev, Russia C.I.S.
15:45 - 15:55
Cell-based non-invasive prenatal testing (cbNIPT): an alternative to chorionic villus sampling to confirm diagnosis of unaffected fetuses following preimplantation genetic testing for monogenic disorders (PGT-M)
Christian Liebst Frisk Toft, Denmark
15:55 - 16:15
Discussion

15:15 - 16:35
Session 47: Does emotional balance before being parents and after exist?
Chairs
Mariana Moura-Ramos, Portugal
Verena Ehrbar, Switzerland
15:15 - 15:25
In-depth analysis of what influences whether patients’ commit to achieve parenthood (parenthood-engagement) and undergo fertility treatment (treatment-engagement) before and after a treatment cycle.
Sofia Gameiro, United Kingdom
15:25 - 15:35
Meditation and mindfulness reduce stress in women with recurrent pregnancy loss: A randomized controlled trial
Karen Henriette Kirchheiner Jensen, Denmark
15:35 - 15:45
The realism of men and women's expected IVF live birth rates
Johanna Devroe, Belgium
15:45 - 15:55
Sperm donor conception and disclosure to children aged from <1 to 17 years old: a follow-up study of parents attitudes and children reactions to disclosure.
Veronique Drouineaud, France
15:55 - 16:05
‘Doing’ kinship: Experiences of non-genetic parenthood of Dutch heterosexual couples using donor sperm treatment
Maria Siermann, The Netherlands
16:05 - 16:15
Mental health in balance of infertility treatment and employment: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) Study
Yuko Ikemoto, Japan
16:15 - 16:35
Discussion

15:15 - 16:30
Session 48: Relating the relevance of biomarkers to infertility
Chairs
Daniela Romualdi, Italy
Dinka Pavicic Baldani, Croatia
15:15 - 15:25
Does higher level of serum folate before ovarian stimulation worsen outcomes of assisted reproductive technologies in normogonadotropic women?
Oleg Sergeyev, Russia C.I.S.
15:25 - 15:35
The mechanism of action of oxytocin receptor antagonists (OTRan) in ART – a study of nolasiban on biomarkers of uterine receptivity in healthy female volunteers
Oliver Pohl, Switzerland
15:35 - 15:45
TRIM28 induces follicular arrest and hyperandrogenism
Ye Liu, China
15:45 - 15:55
Androgens increase accumulation of advanced glycation end products (AGEs) in granulosa cells by activating endoplasmic reticulum (ER) stress in polycystic ovary syndrome (PCOS)
Miyuki Harada, Japan
15:55 - 16:05
Polycystic ovary syndrome and leukocyte telomere length: results of cross-sectional and longitudinal analyses in a birth cohort study
Pekka Pinola, Finland
16:05 - 16:30
Discussion

16:30 - 17:00
Coffee Break Discussion

17:00 - 18:00
Session 49: Embryo metabolism and development
Chairs
Tom Fleming, United Kingdom
Karen Sermon, Belgium
17:00 - 17:10
Human blastocysts show distinct changes in their metabolism between day 5 and 6
Denny Sakkas, U.S.A.
17:10 - 17:20
NMR metabolomics study of follicular fluids reveals specific signature correlated to ART data in endometriosis patients.
Khaled Pocate, France
17:20 - 17:30
Blastocyst quality modulates the generation of an inflammatory microenvironment by decidualized cells
Laura Fernandez, Argentina
17:30 - 17:40
What can we learn from the first 24 hours of embryo development? A fully automated AI-based algorithm for identifying high-quality blastocysts.
Daniella Gilboa, Israel
17:40 - 18:00
Discussion

17:00 - 18:00
Session 50: Androgen treatment in fertility management
Chairs
Thomas Strowitzki, Germany
Yacoub Khalaf, United Kingdom
17:00 - 17:10
A prospective study of testosterone gel treatment in poor ovarian reserve in IVF-ICSI cycles
Randhir Singh, India
17:10 - 17:20
The efficacy and molecular mechanism of dehydroepiandrosterone in diminished ovarian reserve
Cihan Çakır, Turkey
17:20 - 17:30
Endocrine and histological effects of androgen treatment in female-to-male transsexual patients: a study model of long-term high-dose ovarian androgenization
Gemma Casals Soler, Spain
17:30 - 17:40
Association between levels of testosterone /DHEAS at initiation of ovarian stimulation for in vitro-fertilization and the probability of pregnancy: a systematic review and meta-analysis
Viktoria Christoforaki, Greece
17:40 - 18:00
Discussion

17:00 - 18:10
Session 51: RM: new diagnostic and therapeutic aspects
Chairs
Merel van den Berg, The Netherlands
Ole Bjarne Christiansen, Denmark
17:00 - 17:10
The transcriptomic profile of endometrial receptivity in recurrent miscarriage
Laurentiu Craciunas, United Kingdom
17:10 - 17:20
Systematic review and meta-analysis of prevalence of microbiota in ART cycles and recurrent pregnancy loss
Shahin Robati, United Kingdom
17:20 - 17:30
The metabolomic profile of endometrial receptivity in recurrent miscarriage
Justin Chu, United Kingdom
17:30 - 17:40
The precise identification of the window of implantation using the molecular tool ER Map® in ART cycles significantly improves clinical outcomes
Maria Enciso, Spain
17:40 - 17:50
Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis.
Myrthe van Dijk, The Netherlands
17:50 - 18:10
Discussion

17:00 - 18:00
Session 52: AI. a new tool to assess ART outcomes and help patients?
Chairs
Jaime Onofre Meza, Belgium
Lika Chkonia, Georgia
17:00 - 17:10
Patient-oriented counselling: predicting live birth probability (LBP) at each step of the In Vitro Fertilization (IVF) process via machine learning.
Véronika Grzegorczyk Martin, France
17:10 - 17:20
Is IVF making more male embryos and does maternal AMH play a role in this?
Karissa Hammer, U.S.A.
17:20 - 17:30
Time to pregnancy for women using a fertility awareness based mobile application to plan a pregnancy
Jack Pearson, Sweden
17:30 - 17:40
Interactive information provision during IVF/ICSI treatment by using an app: A randomized controlled trial
Jesper M.J. Smeenk, The Netherlands
17:40 - 18:00
Discussion

17:00 - 18:00
Session 53: Controversies in ART
Chairs
Heidi Mertes, Belgium
Margarida Silvestre, Portugal
17:00 - 17:10
Commercial influences on assisted reproductive technology: a scoping review
Wendy Lipworth, Australia
17:10 - 17:20
Expanded carrier screening in medically assisted reproduction: An ethical exploration of a new screening option in the light of professional and parental responsibilities
Sanne van der Hout, The Netherlands
17:20 - 17:30
Ethical justifications of Spanish Fertility Society to preserve anonymity of gamete donation
Rocio Nunez - Calonge, Spain
17:30 - 17:40
First sperm and egg bank in Latin America with open identity donors: a five-year study on patients’ and donors’ preferences between anonymous and open-identity donation.
Pilar Regalado, Argentina
17:40 - 18:00
Discussion

17:00 - 18:00
Session 54: Modern techniques promote variety in fertility nursing research
Chairs
Eline Dancet, Belgium
Alessandra Alteri, Italy
17:00 - 17:10
Pre-selected for an award: The Effect of Hypnofertility on Cortisol Levels, Fertility Preparedness and Pregnancy Rates in Women Undergoing InVitroFertilization: A Randomized Controlled Study
Sevcan Fata, Turkey
17:10 - 17:20
Pre-selected for an award: Assessment of a French web-based patient decision aid (ptDA) of fertility preservation (FP) for women with breast cancer
Alexandra Claire Benoit, France
17:20 - 17:30
Pre-selected for an award: Addressing the psychosocial and informational needs of men with severe male factor infertility (MFI) with a peer-support platform
Eleanor Lowndes Stevenson, U.S.A.
17:30 - 17:40
Pre-selected for an award: A preparatory information movie for the first oocyte aspiration in addition to care as usual: protocol for the POAM randomized controlled trial
Louise Dias, Belgium
17:40 - 18:00
Discussion

18:00 - 19:00
Annual General Assembly of Members
Cristina Magli, Italy
Cornelis Lambalk, The Netherlands
Bruno Van den Eede, Belgium